Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica
Tetsuya Akaishi(Tohoku University Hospital), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Toru Nakazawa(Tohoku University), Toshiyuki Takahashi(Fukushima Medical University), Takayuki Takeshita(Tohoku University), Kimihiko Kaneko(Tohoku University), Masashi Aoki(Tohoku University), Noriko Himori(Tohoku University)
Cited by 37
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
|Neurology Neuroimmunology & Neuroinflammation|2017|432
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
|Frontiers in Neurology|2020|399
Treatment of neuromyelitis optica: Review and recommendations
|Multiple Sclerosis and Related Disorders|2012|263